These findings suggest that PER2 is involved in liver cancer and may be a potential target to improve immunotherapy, contribute to the research and development of new drugs, and provide a strategy and research direction for immunotherapy for HCC. The gene discussed is PER2; the disease is hepatocellular carcinoma.